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Abstract
Background: The rate of development of parasite-specific immune responses can be studied by following their
age profiles in exposed and infected hosts. This study determined the cytokine-age profiles of Zimbabweans
resident in a Schistosoma haematobium endemic area and further investigated the relationship between the
cytokine responses and infection intensity.
Methods: Schistosome adult worm antigen-specific IFN-γ, IL-4, IL-5 and IL-10 cytokine responses elicited from
whole blood cultures were studied in 190 Zimbabweans exposed to S. haematobium infection (aged 6 to 40 years
old). The cytokines were measured using capture ELISAs and the data thus obtained together with S. haematobium
egg count data from urine assays were analysed using a combination of parametric and nonparametric statistical
approaches.
Results: Age profiles of schistosome infection in the study population showed that infection rose to peak in
childhood (11–12 years) followed by a sharp decline in infection intensity while prevalence fell more gradually.
Mean infection intensity was 37 eggs/10 ml urine (SE 6.19 eggs/10 ml urine) while infection prevalence was 54.7%.
Measurements of parasite-specific cytokine responses showed that IL-4, IL-5 and IL-10 but not IFN-γ followed
distinct age-profiles. Parasite-specific IL-10 production developed early, peaking in the youngest age group and
declining thereafter; while IL-4 and IL-5 responses were slower to develop with a later peak. High IL-10 producers
were likely to be egg positive with IL-10 production increasing with increasing infection intensity. Furthermore
people producing high levels of IL-10 produced little or no IL-5, suggesting that IL-10 may be involved in the
regulation of IL-5 levels. IL-4 and IFN-γ did not show a significant relationship with infection status or intensity
and were positively associated with each other.
Conclusion: Taken together, these results show that the IL-10 responses develop early compared to the IL-5
response and may be down-modulating immunopathological responses that occur during the early phase of
infection. The results further support current suggestions that the Th1/Th2 dichotomy does not sufficiently
explain susceptibility or resistance to schistosome infection.
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Background
Schistosomiasis is a major human parasitic disease caused
by trematode parasites of the genus Schistosoma. Of the
three major human schistosome species, S. haematobium,
causing urinary schistosomiasis, is the most prevalent spe-
cies in sub-Saharan Africa where it is responsible for a sub-
stantial amount of schistosome-associated pathology [1].
The role of acquired immunity in reducing schistosome
infection intensity in human populations has been sub-
ject to intense analysis [2-7]. Schistosome immuno-epide-
miology studies have shown that the development of
antigen-specific immune responses is related to cumula-
tive exposure to parasite antigens [8,9] and that the rate of
development of different components of these responses
give distinct profiles across the host age range [10]. These
profiles have facilitated the identification of responses
associated with protection to infection/re-infection. For
example, anti-worm IgE levels were shown to increase
with age in S. haematobium exposed/infected children in
the Gambia, while infection intensity declined [11] and
the combined change in IgA (declining) and IgG1 (rising)
with age in Zimbabwean populations residing in S. hae-
matobium endemic areas was associated with resistance to
infection [12]. Thus an understanding of the rate of devel-
opment of parasite-specific immune responses derived
from age profiles is useful in interpreting susceptibility
and resistance to infection as well as the development of
pathology. This is particularly important for the cellular
responses, which determine the majority of effector func-
tions and immune mediated schistosome pathology [13-
15]. Detailed studies following the development of schis-
tosome-specific cellular responses over a period of time
have been conducted in the mouse model, but such stud-
ies have yet to be conducted in human schistosomiasis
(see [14] for review). Given that differences occur in the
immunology and immunopathology of murine and
human schistosomiasis [16,17], human studies are essen-
tial for a clearer definition of human schistosome
immuno-epidemiology.
Mouse experimental schistosomiasis studies suggest that
the development of effector Th1/Th2 and immuno-mod-
ulatory responses reflect the parasite's developmental
stage (see [14] for review) so that Th1 responses predom-
inate in the early acute phase followed by the emergence
of Th2 responses (stimulated by egg antigens) and
decrease in Th1 responses (down-modulated through an
IL-10-dependent mechanism) [18]. To date, detailed stud-
ies giving an indication of the time course of the develop-
ment of cellular responses against the parasite have not
been performed in human schistosomiasis. Thus this
study aims to determine the cytokine-age profiles of Zim-
babweans resident in S. haematobium endemic areas. The
cytokines to be studied are IFN-γ, a marker for Th1
responses, IL-4 and IL-5, markers for Th2 responses, and
IL-10, originally classified as both a Th1 and Th2 cytokine
in humans [19] but now also seen as a marker for
immuno-modulatory (including regulatory responses)
[18,20,21].
The study also determines the relationship between these
cytokine responses and infection intensity. Previous stud-
ies have suggested that anti-helminth immune responses
fall into a clear Th1 (pro-inflammatory) and Th2 (anti-
inflammatory) dichotomy with resistance to schistosome
infection being associated with Th2 responses [22-25].
More recently there has been mounting evidence that
unlike the intracellular pathogens such as Toxoplasma gon-
dii and Leishmania major where there is a clear polarisation
of the protective response to Th1, the relationship
between the Th1/Th2 dichotomy to the development of
acquired immunity against schistosomes and other
helminths remains unclear ([26-30], see [31] for review).
For example, we have previously shown that anti-egg Th1
and Th2 cytokine responses in S. haematobium infected/
exposed Zimbabwean children did not show a clear pat-
tern with infection intensity [32]. In fact, the Th2
cytokines IL-4 and IL-5 gave contradictory results [32,33].
Our studies and those of others have suggested that some
of the differences reported on the correlation between
Th1/Th2 responses may be related to differences between
schistosome species or to antigens used and/or histories
of infection in diverse epidemiological settings [34]. How-
ever the differences may be a refection of the complexity
of the relationship between cytokine data and infection
intensity which goes beyond the Th1/Th2 dichotomy. We
therefore investigated the relationship between the differ-
ent cytokines (through correlation and data reduction
methods) and used the results from a principal compo-
nent analysis to relate infection intensity to the cytokine
data after describing the epidemiology of the infection in
the population.
Methods
Parasite material
Lyophilised soluble S. haematobium adult worm antigen
(SWAP) was obtained from the Theodor Bilharz Institute
(Egypt) and reconstituted as previously described else-
where [35]. The parasite strain is one used for previous
immuno-epidemiology studies [10].
Study subjects
The study was conducted in the Mashonaland East Prov-
ince of Zimbabwe (31°30'E; 17°45'S) where S. haemato-
bium is endemic. The study area is described in detail
elsewhere [36] and the participants have been participat-
ing in an ongoing study of the immunoepidemiology of
human schistosomiasis [35,37]. Permission to conduct
the work in this province was obtained from the Provin-
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cial Medical Director (PMD) while ethical approval was
received from the Medical Research Council of Zimba-
bwe. Following explanation of the study aims and proce-
dures to the community, school children and their
teachers, informed consent was obtained from partici-
pants or their parents/guardians. The villages were
selected because health surveys regularly conducted in the
region by the PMD showed little or no infection with
other helminths and a low S. mansoni prevalence (<5%).
Prior to our study the selected villages had not been
included in the National Schistosome Control Pro-
gramme (run by the Ministry of Health and Child Welfare
in Zimbabwe) and therefore had not received treatment
for schistosomiasis or other helminth infections meaning
that we could study natural immune responses in the
absence of drug-altered schistosome responses [12,38].
The main activity in these villages is subsistence farming
and human water contact is frequent with at least 4 con-
tacts/person/week due to insufficient safe water and sani-
tation facilities (see [36] for studies in neighbouring
villages). Drinking water is collected from open wells
while bathing and washing is conducted in two main riv-
ers in the villages. Most families maintain a garden located
near the river where water is collected for watering the
crops. The schools surveyed (a secondary school and its
feeder primary school (i.e. where the majority of the pri-
mary school children come from) Goromonzi and
Shangure Schools in Goromonzi Village, and Chindenga
and Nyambanje Schools in Mutoko Village) were all in
close proximity to rivers. Stool and urine specimens were
assayed for S. haematobium, S. mansoni and geohelminths
using standard procedures [39,40]. In order to be
included in the study, participants had to meet all the fol-
lowing criteria: 1) have provided at least 2 urine and 2
stool samples on consecutive days; 2) be negative for
intestinal helminths including S. mansoni (no one was
excluded on this criteria as everyone was negative for these
infections), 3) have given a blood sample. 190 partici-
pants aged 6–40 years met these criteria and formed our
study population. As is standard in all our studies after
collection of all samples, all participants were offered
treatment with the recommended dose of praziquantel
(40 mg/kg of body weight).
Cytokine stimulations and assays
Whole blood stimulations were set up following a proto-
col developed at the University of Cambridge, UK [41]. 10
mls of heparinised venous blood were collected and
immediately diluted 1:4 in RPMI 1640 medium (Sigma)
with penicillin (50 U/ml), streptomycin (50 μg/ml), L-
glutamine (2 mM) (Sigma) and 10% AB serum. 250 μl of
this media was added to a 48-well culture plate which
already contained 25 μl of antigen in RPMI media
described above at 10 μg/ml (SWAP, or Con A) or media
alone. The study focused on responses against whole
worm antigen to provide a complete picture of antibody
and cellular responses against worm antigens (see [35,37]
presenting results of antibody responses of participants
from this population).
Additional cultures were set up to detect the effect of neu-
tralising IL-10 using samples from a subgroup of the par-
ticipants who had provided enough blood to allow
additional assays (n = 17, age range 6–17 years, mean
infection intensity range 0–111 eggs/10 ml urine). For
these cultures, 50 μl/well of 1 μg/ml anti-human IL-10
(rat IgG1 anti-human, JES3-9D7) antibody was added to
half the plate before addition of the whole blood and 50
μl/well of 1 μg/ml isotype control (rat IgG1 R3-34) was
added to the remaining half, so that the same sample was
run on the same plate in wells containing anti-IL-10 anti-
body and the isotype control. The plates were placed in a
glass jar, together with a gas generating kit (Oxoid) and
incubated at 37°C for 48 hrs. Supernatants were harvested
into cryotubes and stored at -20°C in the field prior to
transportation at -20°C to the United Kingdom for analy-
sis. Samples were thawed and all 4 cytokines assayed at
the same time for each sample. IFN-γ, IL-4, IL-5, IL10
cytokine assays were conducted using capture ELISAs with
antibody sets from BD Pharmigen following previously
published protocols [41]. All assays were conducted in
duplicate.
Statistical analyses
Initial analyses were to determine the relationship
between cytokine levels and infection intensity, as well as
between cytokine pairs. After exploratory plots showed
that these relationships were non linear and were direc-
tional (either positive or negative), the analyses were con-
ducted using a one-tailed non parametric Spearman
correlation procedure [42].
The second step was to determine if the cytokines fol-
lowed a distinct age profile. Because of the potential con-
founding relationships of infection intensity, host age and
sex on cytokine levels (see [43]), the effect of infection
intensity and sex on net cytokine level was allowed for
before testing if age had a significant association with net
cytokine level. This was achieved by a multivariate analy-
sis of variance (MANOVA). The dependent and independ-
ent variables were transformed or categorised as
appropriate to satisfy the assumptions of the parametric
tests. Cytokine level (square root transformed) was the
dependent variable and sex (2 categories), age (6 catego-
ries as shown in Table 1) and infection intensity (log10
(x+1) transformed) were the independent variables.
The next statistical tests were to determine the relation-
ship of the cytokine responses (cumulatively) and infec-
tion status. This was achieved by factor analysis using
BMC Infectious Diseases 2007, 7:139 http://www.biomedcentral.com/1471-2334/7/139
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principal components (PCA) [42]. PCA is a standard tech-
nique for reducing multivariate data down to its main
independent features [42]. This procedure was used in this
instance for two reasons (1) to avoid type I and type II
errors in multiple tests using correlated independent vari-
ables [43,44] and (2) to capture the effects of all cytokines
in a single analysis since the responses are likely to be act-
ing simultaneously (see [45]). Following the factor analy-
sis principal components were analyzed further with
logistic regression to determine the risk factors associated
with being infected (egg positive) or uninfected (egg neg-
ative). Independent variables included the principal com-
ponents, sex and age group (categorised as above).
The final statistical test was a two-tailed paired t-test to
determine the effect of blocking IL-10 on cytokine levels
conducted on the square root transformed cytokine data.
All statistical tests were conducted using the software
package SPSS. There is an outlier in the IL-4 data, therefore
all statistical procedures were repeated with the single out-
lier removed; this did not affect the outcome of any of the
statistical tests, so the results reported here include the
outlier. All significant p values (<0.05) were subjected to
Bonferoni testing [46].
Results
Prevalence and intensity of infection
Mean infection intensity for the study population was 37
eggs/10 ml urine with a SE of the mean of 6.19 eggs/10 ml
urine (range 0 eggs – 535 eggs/10 ml urine) while infec-
tion prevalence was 54.7%. Infection prevalence was sim-
ilar across all age groups except in children aged 13–14
and 17–18 where males had higher prevalences than
females. Although these infection levels are moderate rel-
ative to reports from other areas in Zimbabwe [10], the
World Health Organisation denotes this prevalence level
as high and infection intensity also as high as defined by
having more than 10% of the population with >50 eggs/
10 ml of urine (36 of the 190 participants had >50 eggs
per 10 ml urine) [47]. Infection rose to peak in childhood
(11–12 years) followed by a sharp decline in infection
intensity while prevalence fell more gradually as shown in
Figure 1. Infection levels in this population peaked at
lower levels and in older children compared to high infec-
tion areas in Zimbabwe [10]. There were no other
helminth species detected in the participants enrolled for
this study.
S. haematobium antigen specific cytokine responses – age 
profiles
We measured levels of IFN-γ, IL-4, IL-5 and IL-10 in vitro
responses to mitogen (ConA) and parasite adult worm
antigen (SWAP) challenge. In general, responses to ConA
were higher than those against parasite antigens and
spontaneous cytokine production was lower than parasite
and mitogen-induced responses. Of the 190 participants,
the following produced detectable parasite specific
cytokines; 114 (60%) produced IFN-γ, 86 (45%) pro-
duced IL-4, 103 (54%) produced IL-5 and 144 (76%) pro-
duced IL-10, while 32 people (17%) produced all 4
cytokines simultaneously. The most distinct difference
between age profiles of mitogen and parasite-specific
responses was in IL-10 as shown in Figure 2. Levels of IL-
Age-infection profile of the study populationFigure 1
Age-infection profile of the study population. The histograms 
represent mean infection intensity for each age group calcu-
lated using a mean of 3 urine samples/person and bars repre-
sent the standard error of the mean. The line graph 
represents infection prevalence. Sample sizes are given in 
Table 1.
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Table 1: Description of study population
Age group (years) Male (sample size) Female (sample size) Total (sample size) Range of egg counts/10 ml urine
6–10 17 12 29 0–465
11–12 14 17 31 0–535
13–14 18 22 40 0–362
15–16 17 16 33 0–327
17–18 14 9 23 0–168
19+ 7 27 34 0–123
The table gives the sample sizes in each of the age groups represented in Figure 1.
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10 rose to peak with infection intensity in 11–12 year
olds, while levels of IL-4 and IL-5 rose more slowly peak-
ing later in 15–16 year olds.
In order to compare age profiles we had to determine if
the cytokines produced varied with host age after allowing
for the effects of sex and infection intensity. MANOVA
analyses showed that host age significantly affected levels
of parasite-specific IL-4 and IL-5 and IL-10 but not IFN-γ
as shown in Table 2.
Single cytokine patterns with infection intensity
Plots of the relationship between cytokine levels and
infection intensity (Figure 3) indicate that
IFN-γ and IL-4 production did not show significant asso-
ciations with infection intensity. People carrying high lev-
els of infection (>50 eggs/10 ml urine) tended to make
low levels of IL-5 (<10 ng/ml), while people with higher
IL-5 levels had low levels of infection although this rela-
tionship was not statistically significant. IL-10 levels were
Table 2: Output of from the multi-variate analysis of variance 
conducted on all study participants
Cytokine Age group
IFN-γ F = 1.532, df = 5,190, p = 0.182
IL-4 F = 3.277, df = 5,190, p = 0.007
IL-5 F = 4.875, df = 5,190, p < 0.001
IL-10 F = 2.465, df = 5,190, p = 0.034
The analysis determining if cytokine levels varied with host age thus 
testing whether the patterns represented in Figure 2 are significant. 
The statistical procedure allowed for the effects of sex and infection 
intensity on net cytokine level before testing if age had a significant 
effect on net cytokine level. F-value represents the F-test statistic 
from the MANOVA, df = degrees of freedom. Significant p-values are 
in bold.
Age-cytokine profiles for IFN-γ, IL-4, IL-5 and IL-10Figure 2
Age-cytokine profiles for IFN-γ, IL-4, IL-5 and IL-10. Means (net values after subtracting corresponding media values for each 
individual) for each age group are plotted with bars representing standard errors of the mean. Squares represent responses to 
ConA stimulation, and circles represent parasite-specific responses.
0
200
400
600
800
1000
 6-10  11-12  13-14  15-16  17-18  19+
n
g/
m
l
0
5
10
15
20
25
 6-10  11-12  13-14  15-16  17-18  19+
n
g/
m
l
0
20
40
60
 6-10  11-12  13-14  15-16  17-18  19+
n
g/
m
l
0
40
80
120
160
 6-10  11-12  13-14  15-16  17-18  19+
n
g/
m
l ( 
SW
AP
 
 
 
 
 
)
0
400
800
1200
n
g/
m
l (C
o
n
A 
 
 
 
 
 
)
age group
IFN-gamma
IL-10IL-5
IL-4
BMC Infectious Diseases 2007, 7:139 http://www.biomedcentral.com/1471-2334/7/139
Page 6 of 11
(page number not for citation purposes)
significantly correlated to infection intensity and this cor-
relation was positive as shown in Table 3.
Relationship between cytokine levels and infection status
The relationship between infection status (egg positive or
negative) and cytokine response was explored using factor
analysis and logistic regression. The factor analysis
approach was essential in order to reduce the cytokine
data to fewer variables thus minimising problems associ-
ated with multicolinearity [44] as well as to produce vari-
ables containing all the cytokines measured. Factor
analysis gave 2 principal components with the strongest
contributing variables being IFN-γ, IL-4, IL-5 for PCA1
and IL-10 for PCA2. The amount of variation explained by
each of the components is given in Table 4 while the
weightings of each cytokine in the two components is
given in Table 5. Thus the strongest dichotomy in the
immune responses was between the effector T cell
cytokines in PCA1 and the immuno-modulatory cytokine
IL-10 in PCA2. Logistic regression analyses showed that
infection status was significantly affected by PCA 2 (made
up largely of IL-10) (p = 0.039, β = 0.51 with a SE of 0.247,
-2 Log likelihood of 6.522) and that the effect was posi-
tive. Therefore people producing high levels of parasite-
specific IL-10 were significantly more likely to be egg pos-
itive than those producing lower levels of the cytokine.
Table 3: Relationships between cytokine pairs and between 
cytokines and infection intensity
Infection 
intensity
IFN-γ IL-4 IL-5
Infection 
intensity
-
IFN-γ -0.003 -
IL-4 -0.039 0.287** -
IL-5 0.025 0.352** 0.494**
IL-10 0.197** 0.040 0.093 -0.169**
The statistics are from a one tailed non parametric Spearman test. 
This analysis determined whether the relationships in Figure 3 and 
Figure 4 are significant. ** represents correlations were p = 0.01.
Relationship between net parasite-specific cytokine level (ng/ml) and infection intensity (eggs/10 ml urine)Figure 3
Relationship between net parasite-specific cytokine level (ng/ml) and infection intensity (eggs/10 ml urine).
0
500
1000
1500
2000
2500
3000
0 200 400 600
n
g/
m
l
0
50
100
150
200
250
300
0 200 400 600
n
g/
m
l
0
50
100
150
200
250
0 200 400 600
n
g/
m
l
0
200
400
600
800
1000
1200
0 200 400 600
n
g/
m
l
infection intensity
IFN-gamma
IL-5
IL-4
IL-10
BMC Infectious Diseases 2007, 7:139 http://www.biomedcentral.com/1471-2334/7/139
Page 7 of 11
(page number not for citation purposes)
Correlations between cytokines
The relationships between pairs of cytokine are plotted in
Figure 4 and the results from the statistical tests are shown
in Table 3. The most notable correlation was between par-
asite specific IL-10 and IL-5, which was significantly nega-
tive. Other cytokines which were significantly correlated
were INF-y with both IL-4 and IL-5 and IL-4 and IL-5,
which were all positively correlated. IL-4 and Il-10
showed no significant relationship with each other. Peo-
ple produced high levels of either IL-5 (>12 ng/ml) or IL-
10 (>140 ng/ml) but not high levels of both. These signif-
icant positive correlations between INF-y, IL4 and IL-5
and the negative correlation between IL-10 and IL-5 indi-
cate the relationships between the cytokines which under-
lie the PCA analyses.
Effect of blocking IL-10 on levels of IFN-γ, IL-4 and IL-5
Antibody to IL-10 was added to in vitro cultures during
parasite antigen challenge. Blocking IL-10 in this way
resulted in a significant change only in the level of para-
site-specific IL-5, which increased from a mean of 5.15 ng/
ml (SE = 1.39) in the control samples incubated in the
presence of an isotype control to 6.56 ng/ml (SE 1.30) in
the samples incubated in the presence of anti-IL-10 anti-
bodies (T-Value = 3.12, df = 16, p = 0.007). IFN-γ and IL-
4 production did not differ significantly between IL-10
blocked and normal control samples (T = 0.07, df = 16, p
= 0.948; T = -0.62, df = 16, p = 0.542 respectively).
Discussion
This study followed the development of naturally
acquired schistosome-specific cytokine responses with
host age to determine the rate of development of these
responses. We have previously compared the same
cytokine response across populations exposed to different
infection intensities and showed that the rate of develop-
ment of S. haematobium-specific cytokine responses was
affected by the host's history of infection, with responses
developing earlier in areas of high infection intensity
compared to areas of low infection intensity [48]. Here we
compared the profiles of different cytokine responses
within one host population. The cytokines studied were
IFN-γ, a marker for Th1 responses, IL-4 and IL-5, markers
for Th2 responses, and IL-10, originally classified as both
a Th1 and Th2 cytokine in humans [19] but now also seen
as a marker for immuno-modulatory responses including
regulatory T cell responses [18,20,21].
In our study the different cytokines followed distinct age-
profiles with the relationship between age and cytokine
level being significant for IL-4 and IL-5 cytokines believed
to be important in protection against re-infection with S.
haematobium infection [22] as well as IL-10 which has pre-
viously been associated with immunomodulation. Levels
of IL-10 response rose to peak early in childhood declin-
ing thereafter while levels of IL-4 and IL-5 rose more
slowly to peak later with the peak in IL-4 being less pro-
nounced than that of IL-5 so that the age groups where
infection intensity and prevalence are lowest coincide
with high IL-5 and low IL-10. Furthermore the study
showed a positive correlation between IL-10 and infection
intensity which both rose to peak in children aged 11–12
years and declined thereafter. The positive association of
IL-10 and infection intensity has previously been reported
in S. mansoni-exposed Brazilians [34]. Two possible expla-
nations for this positive association are, (1) IL-10 could
simply be reflecting exposure to parasite antigens or (2),
high levels of IL-10 are stimulated by high infection levels
so as to prevent the development of excessive Th2-medi-
ated pathology in addition to Th1-mediated pathology
[14,26]. The latter is consistent with earlier immuno-epi-
demiological studies of S. haematobium infection report-
ing immuno-suppression of schistosome responses in
children [49,50] and Th2 responses in adults with little or
Table 5: Weighting (coefficient) of each cytokine in the values of 
the two principal components
Cytokine Principal component 1 Principal component 2
IFN-γ 0.583 0.270
IL-4 0.888 -0.054
IL-5 0.912 0.072
IL-10 -0.046 0.968
The principal components were extracted by the factor analysis of 
cytokine responses. Strong loadings (> 0.5) are indicated in bold. This 
procedure involves a mathematical procedure that transforms a 
number of correlated variables into a smaller number of uncorrelated 
variables called principal components. The first principal component 
accounts for as much of the variability in the data as possible, and each 
succeeding component accounts for as much of the remaining 
variability as possible [42]. This procedure is valuable for this 
immunology data because it allows the simultaneous effects of all the 
cytokines to be studied at the same time which is a better reflection of 
the biological situation that the standard procedure of studying 
correlations between individual cytokines and infection intensity [43]. 
The two principal components were then used to determine the 
cumulative effects of the cytokine responses on infection status by 
logistic regression.
Table 4: Variance explained by the principal components 
extracted from the cytokine data.
Component Initial eigenvalues
Total % variance Cumulative %
1 1.96 49.07 49.07
2 1.018 25.56 74.53
3 0.782 19.55 94.08
4 0.237 5.92 100
There were 4 principal components extracted from the data. The 
percentage of variance in the cytokine data explained by each of the 
components is given both individually and cumulatively showing that 
the first 2 components explained the greatest percentages.
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no infection [48]. In the mouse model IL-10 reduces
schistosome related liver damage and prolongs host sur-
vival [18], both of which are Th2-mediated, and in human
S. haematobium and S. mansoni infections high IL-10 pro-
duction has been associated with reduced schistosome-
induced pathology(see [17] for review).
There was no correlation between infection intensity and
either IL-4 or IL-5. A previous study in a S. mansoni
endemic Ugandan fishing community suggested that high
IL-5 levels are associated with low S. mansoni levels in
older individuals since high levels coincided with the low-
est infection levels [41]. However, the Ugandan study
showed no significant relationship between current infec-
tion intensity and IL-5 levels. This result is similar to our
current observation that there was no significant correla-
tion between these two parameters. Our study and that
from the Ugandan fishing community support sugges-
tions that IL-5-mediated responses against helminths may
be directed against incoming parasites rather than existing
worm burdens [51,52]. This might also explain the lag
between the age profiles of IL-5 levels and infection inten-
sity we observed in this study.
When the relationship between all the cellular responses
in our study was investigated by factor analysis, responses
were divided into two principal components, i.e. IFN-γ/IL-
4/IL-5 vs. IL-10 dichotomy rather than the more conven-
tional Th1 vs. Th2 dichotomy [22,48,53]. Thus this anal-
ysis divided the cytokine responses into the Th1/Th2
effector responses and the immuno-modulatory IL-10
response. Further analysis of how this dichotomy related
to infection level showed that while the relationship
between the first component and infection level was
unclear, people producing high levels of parasite-specific
IL-10 (represented by the second PCA) being significantly
more likely to be egg positive than those producing lower
levels of the cytokine. These results suggest that the Th1/
Th2 dichotomy may not sufficiently describe the develop-
ment of resistance against schistosomiasis which, is con-
Relationship between pairs of cytokines (net parasite-specific) (ng/ml) showing the positive correlation between all cytokines except IL-10, which when paired with IL-5, shows a negative correlationFigure 4
Relationship between pairs of cytokines (net parasite-specific) (ng/ml) showing the positive correlation between all cytokines 
except IL-10, which when paired with IL-5, shows a negative correlation.
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sistent with previous schistosomiasis studies which have
reported mixed Th1/Th2 responses against adult worm
antigens [41] and current suggestions that the outcome of
helminth infection is related to the balance between effec-
tor (Th1/Th2) and regulatory responses [54]. The IL-10
response in this population was negatively correlated with
the IL-5 response and blocking IL-10 resulted in an
increase in parasite-specific IL-5 produced. Taken together
these results support the proposition that in schistosomia-
sis at least, IL-10 is acting as a regulatory cytokine which
inhibits a protective IL-5 dependent response
[3,17,18,55]. Various cells have been implicated in IL-10
production [26,56] but the distinct cellular sources of this
cytokine remain poorly defined in both human and
experimental schistosomiasis. We are therefore currently
determining the source of the parasite-specific IL-10
measured in this study.
Conclusion
Taken together, our results show first that the IL-10
response occurs early, peaking in young children, suggest-
ing that immuno-modulatory responses are already
present in the young age groups indicating a parallel to
the mouse model of schistosomiasis in which IL-10
down-modulates the early phase of infection [14]. Of
course such parallels have to be interpreted with caution
as human studies differ from experimental models in
many respects not least by the lack of a precise measure of
the point of infection in an endemic population and more
so because of the potential for sensitisation to parasite
antigens in utero [57,58]. Second, our data indicate that
IL-10 may be exerting its modulatory effect by down-reg-
ulating IL-5 production. More broadly our results also
support current hypotheses suggesting that the balance
between effector and immuno-modulatory responses is
an important factor in the development of acquired resist-
ance to schistosomes [26,59].
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